BILL · 2005–06 SESSION

HB 1017: Pseudoephedrine

Restricting the sale of pseudoephedrine to licensed pharmacists.

Summary

Limits the authority to sell products containing ephedrine, pseudoephedrine, or phenylpropanolamine to consumers to authorized health care practitioners.

From the House Bill Analysis (HB 1017), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to restricting the sale of pseudoephedrine to licensed pharmacists;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 1017 (2025–26) Kimchi day · Did not pass · stalled on the House floor
HB 1017 (2023–24) Cosmetologists, etc/licenses · Enacted · Chapter 55, Laws of 2023
HB 1017 (2021–22) Emergency order oversight · Did not pass · died in committee
HB 1017 (2019–20) Health carrier salaries · Did not pass · died in committee
HB 1017 (2017–18) School siting · Enacted with partial veto · Chapter 129, Laws of 2017
HB 1017 (2015–16) Misdemeanor convictions · Did not pass · died in committee
HB 1017 (2013–14) Efficiency standards · Did not pass · passed House, stalled in Senate
HB 1017 (2011–12) DUI twelve-hour impound hold · Did not pass · died in committee